COAGNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Hemab Therapeutics Holdings, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 11, 2026
$32.09+2.02 (+6.72%)
Close on Oct 19, 2026
- Market cap
- $966.27M
- P/E (TTM)
- –
- Dividend yield
- –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Held by institutions
77.5%
36M of 47M shares
Institutional holders
55
55 new, 0 sold out
Net institutional buying
36M
In Q2 2026
Insider trades, 12 months
16 buys · 0 sales
Net bought $55.46M
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| RA Capital Management, L.P. | 7,729,773 | 16.60% | 13G (passive) | May 4, 2026 |
| Access Industries Management LLC | 4,876,344 | 10.40% | 13D (active) | May 4, 2026 |
| Novo Holdings A/S | 4,180,550 | 9.00% | 13G (passive) | Jun 30, 2026 |
| FMR LLC | 3,697,837 | 7.90% | 13G (passive) | Jun 30, 2026 |
| Capital International Investors | 3,603,876 | 7.70% | 13G (passive) | Jun 30, 2026 |
| David Kroin | 3,600,996 | 8.15% | 13G (passive) | May 1, 2026 |
| Behzad Aghazadeh | 3,298,236 | 7.06% | 13G (passive) | Jun 30, 2026 |
| Kinam Hong | 2,511,212 | 5.40% | 13G (passive) | Jun 30, 2026 |
| Raymond Debbane | 2,366,235 | 5.10% | 13G (passive) | Aug 3, 2026 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of COAG | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Ra Capital Management, L.P. | 7,808,627 | 16.72% | $286.81M | New | 2.49% |
| Novo Holdings A/S | 4,180,550 | 8.95% | $153.55M | New | 8.92% |
| FMR LLC | 3,697,837 | 7.92% | $135.82M | New | 0.01% |
| Capital International Investors | 3,603,876 | 7.72% | $132.37M | New | 0.03% |
| Deep Track Capital, LP | 3,602,093 | 7.71% | $132.30M | New | 1.93% |
| Siren, L.L.C. | 2,086,834 | 4.47% | $76.65M | New | 1.55% |
| Avoro Capital Advisors LLC | 1,925,150 | 4.12% | $70.71M | New | 0.63% |
| Bain Capital Life Sciences Investors, LLC | 1,650,000 | 3.53% | $60.60M | New | 3.60% |
| JPMorgan Chase & Co | 1,152,420 | 2.47% | $42.33M | New | 0.00% |
| Vanguard Capital Management LLC | 780,758 | 1.67% | $28.68M | New | 0.00% |
| Price T Rowe Associates Inc /Md/ | 746,040 | 1.60% | $27.40K | New | 0.00% |
| Driehaus Capital Management LLC | 715,791 | 1.53% | $26.29M | New | 0.15% |
| Rock Springs Capital Management LP | 575,432 | 1.23% | $21.14M | New | 1.03% |
| Bellevue Group AG | 550,000 | 1.18% | $20.20M | New | 0.43% |
| Citadel Advisors LLC | 523,450 | 1.12% | $19.23M | New | 0.00% |
| BlackRock, Inc. | 283,833 | 0.61% | $10.43M | New | 0.00% |
| Deerfield Management Company, L.P. (Series C) | 275,000 | 0.59% | $10.10M | New | 0.11% |
| ExodusPoint Capital Management, LP | 218,287 | 0.47% | $8.02M | New | 0.05% |
| Geode Capital Management, LLC | 211,798 | 0.45% | $7.78M | New | 0.00% |
| Braidwell LP | 160,000 | 0.34% | $5.88M | New | 0.22% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 55 | 36M | 77.5% | 55 / 0 | 0 / 0 | 36M | 0M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
| Fund | Shares | % of COAG | Value | % of fund | As of |
|---|---|---|---|---|---|
| SMALLCAP World Fund Inc | 2,157,914 | 4.62% | $79.26M | 0.08% | Jun 30, 2026 |
| SMALLCAP World Fund Inc | 1,348,629 | 2.89% | $49.54M | 0.05% | Jun 30, 2026 |
| Vanguard Total Stock Market Index Fund | 555,543 | 1.19% | $20.41M | 0.00% | Jun 30, 2026 |
| JPMorgan Small Cap Growth Fund | 531,382 | 1.14% | $19.52M | 0.75% | Jun 30, 2026 |
| Fidelity Growth Company Fund | 524,500 | 1.12% | $14.95M | 0.02% | May 31, 2026 |
| Fidelity Stock Selector Small Cap Fund | 439,953 | 0.94% | $20.92M | 0.28% | Jul 31, 2026 |
| Strategic Advisers Fidelity U.S. Total Stock Fund | 412,400 | 0.88% | $11.75M | 0.00% | May 31, 2026 |
| Select Biotechnology Portfolio | 379,476 | 0.81% | $10.82M | 0.21% | May 31, 2026 |
| Fidelity Series Small Cap Opportunities Fund | 267,754 | 0.57% | $12.73M | 0.27% | Jul 31, 2026 |
| Fidelity Blue Chip Growth Fund | 236,200 | 0.51% | $11.23M | 0.01% | Jul 31, 2026 |
| T. Rowe Price Health Sciences Fund, Inc. | 206,840 | 0.44% | $7.60M | 0.06% | Jun 30, 2026 |
| Vanguard Extended Market Index Fund | 203,551 | 0.44% | $7.48M | 0.01% | Jun 30, 2026 |
| Fidelity Advisor Biotechnology Fund | 186,700 | 0.40% | $8.88M | 0.40% | Jul 31, 2026 |
| T. Rowe Price New Horizons Fund, Inc. | 174,541 | 0.37% | $6.41M | 0.04% | Jun 30, 2026 |
| JPMorgan Small Cap Blend Fund | 171,281 | 0.37% | $6.29M | 0.37% | Jun 30, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Benny Sorensen | See Remarks, Director | – | – | Apr 30, 2026 |
| Catherine Madigan | Chief Medical Officer | – | – | May 4, 2026 |
| Mads Nikolaj Behrndt-Eriksen | See Remarks | 36,520 | 0.08% | May 4, 2026 |
| Ananthram Sreenivasa Murthy | Chief Operating Officer | – | – | Apr 30, 2026 |
| Keli Walbert | Director | – | – | Sep 25, 2026 |
| RA Capital Nexus Fund IV, L.P. | Director | – | – | May 6, 2026 |
| RA Capital Nexus Fund II, L.P. | Director | – | – | May 6, 2026 |
| John Maraganore | Director | 17,974 | 0.04% | May 4, 2026 |
| Linda Bain | Director | – | – | Apr 30, 2026 |
| Laura Tadvalkar | Director | – | – | Apr 30, 2026 |
| Akshay Vaishnaw | Director | – | – | Apr 30, 2026 |
| Ra Capital Management, L.P. | 10% owner | 6,444,637 | 13.80% | Jun 17, 2026 |
| Capital Healthcare Fund LP RA | 10% owner | 6,340,063 | 13.57% | Jun 17, 2026 |
| Peter Kolchinsky | 10% owner | 6,372,170 | 13.64% | Jun 17, 2026 |
| Rajeev M. Shah | 10% owner | 6,261,118 | 13.40% | Jun 17, 2026 |
| Den-Mab Llc Ai | 10% owner | 4,876,344 | 10.44% | May 14, 2026 |
| Len Blavatnik | 10% owner | – | – | May 14, 2026 |
| Access Industries Management, Llc | 10% owner | – | – | May 14, 2026 |
| Industries Holdings LLC Access | 10% owner | – | – | May 14, 2026 |
| Biotechnology LLC AI | 10% owner | – | – | May 14, 2026 |
| Holdings A/S Novo | 10% owner | 4,180,550 | 8.95% | May 6, 2026 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Ra Capital Management, L.P. 10% owner | Jun 16, 2026 | Buy | +61,523 | $24.98 | $1.54M | 6,444,637 |
| Ra Capital Management, L.P. 10% owner | Jun 15, 2026 | Buy | +6,146 | $24.89 | $152.97K | 6,383,114 |
| Ra Capital Management, L.P. 10% owner | May 20, 2026 | Buy | +996 | $24.94 | $24.84K | 6,376,968 |
| Ra Capital Management, L.P. 10% owner | May 19, 2026 | Buy | +3,802 | $24.97 | $94.94K | 6,375,972 |
| Peter Kolchinsky 10% owner | May 12, 2026 | Buy | +6,387 | $24.90 | $159.04K | 6,372,170 |
| Capital Healthcare Fund LP RA 10% owner | May 11, 2026 | Buy | +14,149 | $24.47 | $346.23K | 6,340,063 |
| Capital Healthcare Fund LP RA 10% owner | May 11, 2026 | Buy | +25,720 | $25.00 | $643.00K | 6,365,783 |
| Capital Healthcare Fund LP RA 10% owner | May 8, 2026 | Buy | +1,483 | $24.98 | $37.05K | 6,325,914 |
| Capital Healthcare Fund LP RA 10% owner | May 7, 2026 | Buy | +7,921 | $24.34 | $192.80K | 6,322,446 |
| Capital Healthcare Fund LP RA 10% owner | May 7, 2026 | Buy | +1,985 | $24.95 | $49.53K | 6,324,431 |
| Rajeev M. Shah Director, 10% owner | May 6, 2026 | Buy | +14,611 | $23.77 | $347.30K | 6,261,118 |
| Rajeev M. Shah Director, 10% owner | May 6, 2026 | Buy | +53,407 | $24.83 | $1.33M | 6,314,525 |
| Rajeev M. Shah Director, 10% owner | May 5, 2026 | Buy | +87,143 | $24.59 | $2.14M | 6,236,239 |
| Rajeev M. Shah Director, 10% owner | May 5, 2026 | Buy | +10,268 | $25.00 | $256.70K | 6,246,507 |
| Rajeev M. Shah Director, 10% owner | May 4, 2026 | Conversion | +1,009,052 | – | – | 1,009,052 |
| Rajeev M. Shah Director, 10% owner | May 4, 2026 | Conversion | +221,188 | – | – | 221,188 |
| Rajeev M. Shah Director, 10% owner | May 4, 2026 | Buy | +2,541,250 | $18.00 | $45.74M | 6,149,096 |
| Rajeev M. Shah Director, 10% owner | May 4, 2026 | Buy | +133,750 | $18.00 | $2.41M | 354,938 |
| Rajeev M. Shah Director, 10% owner | May 4, 2026 | Conversion | +3,607,846 | – | – | 3,607,846 |
| Holdings A/S Novo 10% owner | May 4, 2026 | Conversion | +4,180,550 | – | – | 4,180,550 |
| John Maraganore Director | May 4, 2026 | Conversion | +17,974 | – | – | 17,974 |
| John Maraganore Director | May 4, 2026 | Conversion | +17,974 | – | – | 35,948 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.